/Investor DB

Asset Management Company — 2015 Investments

4 investments dated 2015 · listed companies and verified rows first · show all

Freenomefreenome.comin𝕏NASDAQ: FRNMOct 2015

Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, US

Riley Ennis(Founder)inCharles Roberts(Founder)inGabriel Otte(Founder)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)

Co-investorsRA CapitalAgent CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAverin Capital+15 more

Oomaooma.comin𝕏NYSE: OOMAApr 2015

Ooma Direct Routing for Microsoft Teams enables organizations to connect their Teams collaboration platform to the Public Switched Telephone Network for voice calling.

Cloud ComputingConsumerEnterprise SoftwareFuture of WorkSaaSPalo Alto, US

Andrew FrameinSpencer Jackson(Executive Officer)inEric B. Stang(President and Chief Executive Officer)inShig Hamamatsu(Senior Vice President and Chief Financial Officer)inJenny C. Yeh(Senior Vice President and Chief Legal Officer)inNamrata Sabharwal(Chief Accounting Officer)in

Co-investorsWestern Technology InvestmentWI Harper Group

UniKey Technologiesunikey.cominSeries A · Apr 2015 · $10M

UniKey provides mobile credential technology for lock and access control manufacturers, enabling integration with Apple Wallet, Google Wallet, and Bluetooth.

HardwareIoTSaaSOrlando, US

PHIL DUMAS(Executive Officer, Director)in

BoardJOHN FRANKEL(Director)inRICHARD SIMONI(Director)MANUEL KADRE(Director)STEVEN FISKE(Director)in

Co-investorsAkkadian VenturesDaniel GutenbergFf Venture CapitalKombo VenturesLauder PartnersRealization Capital Partners+2 more

WellDocwelldoc.comin𝕏Jul 2015

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.

AI & Machine LearningDigital HealthHealthtechBaltimore, US

Ryan Sysko(Executive Officer, Director)inSuzanne Clough(Executive Officer)inKevin McRaith(President and CEO)inAnand Iyer(Chief AI Officer)inChris Bergstrom(Executive Officer)in

BoardTerry Lierman(Director)

Co-investorsMerck Global Health Innovation FundSamsung VenturesDigiTx Partners LLCExcel Venture ManagementMSD Global Health Innovation FundTCP Venture Capital+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.